Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
4
pubmed:dateCreated
2007-4-13
pubmed:abstractText
Few treatment options are available for metastatic breast cancer with resistance to both anthracycline-and taxane-based chemotherapy regimens. Docetaxel combined capecitabine (DC regimen) is approved as a new active regimen for metastatic breast cancer. This study was to explore the efficacy of DC regimen on metastatic breast cancer, and evaluate its safety.
pubmed:language
chi
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Apr
pubmed:issn
1000-467X
pubmed:author
pubmed:issnType
Print
pubmed:volume
26
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
407-10
pubmed:meshHeading
pubmed-meshheading:17430662-Administration, Oral, pubmed-meshheading:17430662-Adult, pubmed-meshheading:17430662-Antineoplastic Combined Chemotherapy Protocols, pubmed-meshheading:17430662-Bone Neoplasms, pubmed-meshheading:17430662-Breast Neoplasms, pubmed-meshheading:17430662-Carcinoma, Ductal, Breast, pubmed-meshheading:17430662-Deoxycytidine, pubmed-meshheading:17430662-Disease-Free Survival, pubmed-meshheading:17430662-Fatigue, pubmed-meshheading:17430662-Female, pubmed-meshheading:17430662-Fluorouracil, pubmed-meshheading:17430662-Follow-Up Studies, pubmed-meshheading:17430662-Humans, pubmed-meshheading:17430662-Infusions, Intravenous, pubmed-meshheading:17430662-Leukopenia, pubmed-meshheading:17430662-Liver Neoplasms, pubmed-meshheading:17430662-Lung Neoplasms, pubmed-meshheading:17430662-Lymphatic Metastasis, pubmed-meshheading:17430662-Middle Aged, pubmed-meshheading:17430662-Remission Induction, pubmed-meshheading:17430662-Taxoids
pubmed:year
2007
pubmed:articleTitle
[Efficacy of docetaxel combined capecitabine on metastatic breast cancer].
pubmed:affiliation
State Key Laboratory of Oncology in South China, Guangzhou, Guangdong, 510060, P. R. China.
pubmed:publicationType
Journal Article, Clinical Trial, English Abstract